Results

Total Results: 441 records

Showing results for "hypertension".
Users also searched for: diabetes

101. Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-disease-therapies/abstract

102. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - bowel, liver, pancreatic, inflammatory or vascular disease, stroke, medication for hyperlipidemia, hypertension … 45–70 y, >1 y postmenopausal (self-reported) smoking, chronic illnesses (diabetes or CVD), untreated hypertension … serum high-density lipoprotein (HDL) cholesterol ≤1.03mmol/L for men and ≤1.29mmol/L for women) or hypertension … (systolic blood pressure (BP) >130mm Hg or medical treatment of hypertension) Pharmacological treatment … ; hypertension, diabetes and blood lipid regulation, Lactating (or lactating, 6 wk ago), pregnant (or

103. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - bowel, liver, pancreatic, inflammatory or vascular disease, stroke, medication for hyperlipidemia, hypertension … 45–70 y, >1 y postmenopausal (self-reported) smoking, chronic illnesses (diabetes or CVD), untreated hypertension … serum high-density lipoprotein (HDL) cholesterol ≤1.03mmol/L for men and ≤1.29mmol/L for women) or hypertension … (systolic blood pressure (BP) >130mm Hg or medical treatment of hypertension) Pharmacological treatment … ; hypertension, diabetes and blood lipid regulation, Lactating (or lactating, 6 wk ago), pregnant (or

104. Self-Measured Blood Pressure: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/measuring-blood-pressure-future/research

105. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - types of glaucoma may also be described in the literature as the following conditions: • Ocular hypertension … Source: www.effectivehealthcare.ahrq.gov Published Online: November 16, 2010 ("Ocular Hypertension … "[mh] OR "ocular hypertension"[tiab] OR "Intraocular Pressure"[mh] OR "intraocular pressure"[tiab] … The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive

106. Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update

107. Cervical Ripening in the Outpatient Setting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
     December 18, 2019 - maternal hypertension or diabetes, fetal growth restriction, and in postterm pregnancies).2,3 In addition … maternal subgroups: parity, maternal age, GBS status, diabetes (pre- gestational, gestational), hypertension … maternal subgroups: parity, maternal age, GBS status, diabetes (pre- gestational, gestational), hypertension … including maternal age, gestational age, race and ethnicity), pregnancy risk factors (such as diabetes, high … blood pressure, pre-eclampsia), obstetric factors (e.g. parity), maternal pre-pregnancy health status

108. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - Vitamin D and Hypertension and Blood Pressure Hypertension For the current report we identified no … No studies evaluated the relationship of vitamin D with or without calcium and pregnancy-related high … blood pressure, preterm birth, or small infant for gestational age. 11 Combined Vitamin D and … For the original report, only the B-rated WHI trial evaluated the risk of developing hypertension. … supplementation had no effect on incident hypertension.

109. Glaucoma-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
     April 01, 2012 - (2009) enrolled 130 participants with ocular hypertension and 48 healthy volunteers.18 Using a cutoff … The investigators of the evidence report Primary Care Screening for Ocular Hypertension and Primary … Ability of optical imaging devices to detect early structural damage in ocular hypertension. … Quantification of retinal nerve fiber layer thickness in normal eyes, eyes with ocular hypertension … Quantification of retinal nerve fiber layer thickness in normal eyes, eyes with ocular hypertension

110. Blood Pressure Medicines | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/blood-pressure-medicines

111. BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
     June 01, 2010 - • Disease surveillance: identify the first diagnosis of hypertension within two years of an index … antihypertensive treatment or a hospitalization for a myocardial infarction or stroke after first treatment for hypertension

112. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, tx, kw, ct, sh, bt, id, cc] 51. exp hypertension/ … intermediate CVD risk • Adults without CVD but with high risk (e.g., diabetes, metabolic syndrome, hypertension … angina with confirming clinical tests) • Adults (≥18 y) o Include: Diabetes, Metabolic Syndrome, Hypertension … to dissolve clot) • Major CVD risk factors (intermediate outcomes): o blood pressure (new-onset hypertension … blood pressure and lipids [tag as maybe] • Timing o Clinical outcomes, including new-onset hypertension

113. Renal Artery Stenosis Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-update/research-protocol

114. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - disease (including ischemic heart disease, myocardial infarction, and acute coronary syndrome)  Hypertension … with a priority condition (i.e. breast cancer, colorectal cancer, diabetes, congestive heart failure, hypertension … disease (including ischemic heart disease, myocardial infarction, and acute coronary syndrome)  Hypertension … states: Priority conditions include: colorectal cancer screening; diabetes; congestive heart failure; hypertension

115. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
     October 12, 2015 - used for male infertility, insurance status, and presence or absence of common comorbidities such as hypertension … hypertension!and!diabetes! [KQ!1]! o! diagnostic!criteria/evaluationO!stage!of!endometriosisO! … hypertension!and!diabetes! [KQ!2]! o! diagnostic!criteria/evaluationO!presence!or!absence!of! … hypertension!and!diabetesO! women!without!male!partners!(single!women!or!lesbian! couples)![KQ! … hypertension!and!diabetes.! ! KQ!6:! •! Women!of!reproductive!age!(18044)!who!are!potential!

116. Presentation of Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
     April 01, 2012 - ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DR) for ―Treating Hypertension … ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Treating Hypertension … (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Treating Hypertension … arterial disease, chronic kidney disease) on ACEI/ARB/DRI effectiveness or harms in patients with hypertension … Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors (DRIs) in the Treatment of Hypertension

117. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - Demographic subgroups: age, sex, and race • Coexisting diseases: cardiovascular conditions, such as hypertension … , consistent differences between celecoxib, partially selective, and nonselective NSAIDs in risk of hypertension … Pre-existing disease including history of previous bleeding due to NSAIDs or peptic ulcer disease; hypertension … , edema, ischemic heart disease, and heart failure Moderate for previous bleeding Moderate for hypertension … Food and Drug Administration; GI = gastrointestinal; H2 = histamine 2; HR = hazard ratio; HTN = hypertension

118. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - Comorbidities (e.g., diabetes, hypertension) i. … Comorbidities (e.g., diabetes, hypertension) i. … Comorbidities (e.g., diabetes, hypertension) i. … Comorbidities (e.g., diabetes, hypertension) i. Smoking status j. 10-year CHD risk k. … EKG changes (for patients with clinically suspected ACS only)  Comorbidities (e.g., diabetes, hypertension

119. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
     June 01, 2016 - lived — such as Cushingoid facies, irritability or mood changes, growth retardation, infection, and hypertension … effects, including Cushingoid facies, growth retardation, mood changes/ irritability, abdominal pain, hypertension

120. Self-Measured Blood Pressure Monitoring | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/measuring-blood-pressure/research-protocol